Gangrene primary prevention

	Gangrene Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Gangrene from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Gangrene primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Gangrene primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Gangrene primary prevention
CDC on Gangrene primary prevention
Gangrene primary prevention in the news
Blogs on Gangrene primary prevention
Directions to Hospitals Treating Gangrene
Risk calculators and risk factors for Gangrene primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.

Overview

Gas gangrene can be prevented by always monitoring the blood glucose levels and maintaining them within the normal range, and regular foot inspection, especially in those patients with diabetes. Post-exposure prophylaxis may be needed by immunocompromised individuals if they were in close contact with patients with necrotizing infection due to Group A streptococcus. ^[1] Droplet and contact precautions are warranted to these susceptible individuals. ^[2]

Gas gangrene can be prevented by always monitoring the blood glucose levels and maintaining them within the normal range, and regular foot inspection, especially in those patients with diabetes.
Post-exposure prophylaxis may be needed by immunocompromised individuals if they were in close contact with patients with necrotizing infection due to Group A streptococcus. ^[1]
Droplet and contact precautions are warranted to these susceptible individuals. ^[2]

↑ ^1.0 ^1.1 Luzhnikov EA, Ananchenko VG, Bokarev IM, Akhtomova LV, Bochkarnikova OV (1976). "[Role of hemostasis in the development and prevention of pneumonia in patients with acute poisoning]". Sov Med (9): 146–8. PMID 0996606.
↑ ^2.0 ^2.1 Siegel JD, Rhinehart E, Jackson M, Chiarello L, Health Care Infection Control Practices Advisory Committee (2007). "2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings". Am J Infect Control. 35 (10 Suppl 2): S65–164. doi:10.1016/j.ajic.2007.10.007. PMC 7119119 Check |pmc= value (help). PMID 18068815.